Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 06:55:44 UTC |
---|
Update Date | 2021-09-26 23:01:08 UTC |
---|
HMDB ID | HMDB0249963 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester |
---|
Description | N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-{1-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]-4-(methoxycarbonyl)piperazin-2-yl}ethanimidic acid belongs to the class of organic compounds known as n-arylpiperazines. These are organic compounds containing a piperazine ring where the nitrogen ring atom carries an aryl group. Based on a literature review very few articles have been published on N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-{1-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]-4-(methoxycarbonyl)piperazin-2-yl}ethanimidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). 3-{[(benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | COC(=O)N1CCN(C(CC(=O)NCC2=CC3=C(OCO3)C=C2)C1)C1=NC(=NC=C1)N1C=CN=C1 InChI=1S/C23H25N7O5/c1-33-23(32)28-8-9-30(20-4-5-25-22(27-20)29-7-6-24-14-29)17(13-28)11-21(31)26-12-16-2-3-18-19(10-16)35-15-34-18/h2-7,10,14,17H,8-9,11-13,15H2,1H3,(H,26,31) |
---|
Synonyms | Value | Source |
---|
N-[(2H-1,3-Benzodioxol-5-yl)methyl]-2-{1-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]-4-(methoxycarbonyl)piperazin-2-yl}ethanimidate | Generator | 3-{[(benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylate methyl ester | Generator |
|
---|
Chemical Formula | C23H25N7O5 |
---|
Average Molecular Weight | 479.497 |
---|
Monoisotopic Molecular Weight | 479.191716933 |
---|
IUPAC Name | methyl 3-({[(2H-1,3-benzodioxol-5-yl)methyl]carbamoyl}methyl)-4-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]piperazine-1-carboxylate |
---|
Traditional Name | methyl 3-{[(2H-1,3-benzodioxol-5-ylmethyl)carbamoyl]methyl}-4-[2-(imidazol-1-yl)pyrimidin-4-yl]piperazine-1-carboxylate |
---|
CAS Registry Number | Not Available |
---|
SMILES | COC(=O)N1CCN(C(CC(=O)NCC2=CC3=C(OCO3)C=C2)C1)C1=NC(=NC=C1)N1C=CN=C1 |
---|
InChI Identifier | InChI=1S/C23H25N7O5/c1-33-23(32)28-8-9-30(20-4-5-25-22(27-20)29-7-6-24-14-29)17(13-28)11-21(31)26-12-16-2-3-18-19(10-16)35-15-34-18/h2-7,10,14,17H,8-9,11-13,15H2,1H3,(H,26,31) |
---|
InChI Key | NVYMEDQKBQMAKF-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as n-arylpiperazines. These are organic compounds containing a piperazine ring where the nitrogen ring atom carries an aryl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazinanes |
---|
Sub Class | Piperazines |
---|
Direct Parent | N-arylpiperazines |
---|
Alternative Parents | |
---|
Substituents | - N-arylpiperazine
- Beta amino acid or derivatives
- Benzodioxole
- Piperazine-1-carboxylic acid
- Imidazolyl carboxylic acid derivative
- Dialkylarylamine
- Aminopyrimidine
- N-substituted imidazole
- Imidolactam
- Benzenoid
- Pyrimidine
- Methylcarbamate
- Azole
- Imidazole
- Heteroaromatic compound
- Carbamic acid ester
- Carboxamide group
- Secondary carboxylic acid amide
- Azacycle
- Oxacycle
- Carboxylic acid derivative
- Acetal
- Organonitrogen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organooxygen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester,1TMS,isomer #1 | COC(=O)N1CCN(C2=CC=NC(N3C=CN=C3)=N2)C(CC(=O)N(CC2=CC=C3OCOC3=C2)[Si](C)(C)C)C1 | 4205.0 | Semi standard non polar | 33892256 | 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester,1TMS,isomer #1 | COC(=O)N1CCN(C2=CC=NC(N3C=CN=C3)=N2)C(CC(=O)N(CC2=CC=C3OCOC3=C2)[Si](C)(C)C)C1 | 4281.5 | Standard non polar | 33892256 | 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester,1TMS,isomer #1 | COC(=O)N1CCN(C2=CC=NC(N3C=CN=C3)=N2)C(CC(=O)N(CC2=CC=C3OCOC3=C2)[Si](C)(C)C)C1 | 6144.3 | Standard polar | 33892256 | 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester,1TBDMS,isomer #1 | COC(=O)N1CCN(C2=CC=NC(N3C=CN=C3)=N2)C(CC(=O)N(CC2=CC=C3OCOC3=C2)[Si](C)(C)C(C)(C)C)C1 | 4393.6 | Semi standard non polar | 33892256 | 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester,1TBDMS,isomer #1 | COC(=O)N1CCN(C2=CC=NC(N3C=CN=C3)=N2)C(CC(=O)N(CC2=CC=C3OCOC3=C2)[Si](C)(C)C(C)(C)C)C1 | 4474.8 | Standard non polar | 33892256 | 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester,1TBDMS,isomer #1 | COC(=O)N1CCN(C2=CC=NC(N3C=CN=C3)=N2)C(CC(=O)N(CC2=CC=C3OCOC3=C2)[Si](C)(C)C(C)(C)C)C1 | 6123.3 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester GC-MS (Non-derivatized) - 70eV, Positive | splash10-000i-2946200000-e1895bcbf453c9b09ac5 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester 10V, Negative-QTOF | splash10-004j-0000900000-7bc3d5fa5f64f2aa0d88 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester 20V, Negative-QTOF | splash10-01t9-0141900000-1ab01e2f7b2e295e3c77 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester 40V, Negative-QTOF | splash10-00kf-3092100000-a135df33e8c89dbdef4b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester 10V, Positive-QTOF | splash10-001i-0000900000-33baf7f793b6aa890f5b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester 20V, Positive-QTOF | splash10-001j-0201900000-8dc94ead6cda33668042 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester 40V, Positive-QTOF | splash10-000i-5922200000-f7ef105398d92f2251b4 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|